Card image cap

Pete Sessions' Public Statements on Issue: Drugs

Office:

On The Ballot: Running, Republican for U.S. House (TX) - District 17

Current Issue:

Drugs

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Date Title
09/13/2018 Sessions, McCaul Crack Down on Border Tunnel Threat
05/22/2018 Letter to President Donald Trump - Maintain the Fight Against Drug Trafficking
07/12/2017 Sessions Applauds Passage of Bill to Strengthen the Physician - Patient Relationship
03/10/2017 Sessions Introduces Medical Controlled Substances Transportations Act
07/08/2016 Sessions Applauds House-Senate Conference Report on the Comprehensive Addiction and Recovery Act
05/13/2016 Sessions Supports Package of Bills to Combat the Opioid Epidemic
05/11/2016 Establishing Pain Management Best Practices Inter-Agency Task Force
03/24/2015 Letter to Chairman Ander Crenshaw and Ranking Member Jose E. Serano, Subcommittee on Financial Services and General Government House Committee on Appropriations - Bipartisan Call to Stop Drug Trafficking
09/09/2014 Sessions Sounds Alarm Over HHS Policy Allowing Welfare Cash To Be Withdrawn In Marijuana Stores
06/14/2011 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act. 2012
10/14/2008 Sessions Applauds Grand Opening of Phoenix House IMPACT Program for At-Risk Youth
08/02/2007 Providing for Further Consideration of H.R. 3161, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations ..
08/02/2007 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
04/25/2007 Sessions Recognizes Decrease in Medicare Hospitalizations
01/12/2007 Medicare Prescription Drug Price Negotiation Act of 2007
12/08/2006 Dietary Supplement And Nonprescription Drug Consumer Protection Act
03/09/2006 Providing for Consideration of H.R. 2829, Office of National Drug Control Policy
02/25/2004 Homeland Security Science and Technology Budget Hearing
arrow_upward